Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Endometrial Hyperplasia × Metformin × Clear all

Phase

Phase 4 1 Phase 2 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 21 Breast Neoplasms 18 Carcinoma, Non-Small-Cell Lung 11 Polycystic Ovary Syndrome 9 Colorectal Neoplasms 9 Lung Neoplasms 8 Pancreatic Neoplasms 6 Endometrial Neoplasms 6 Neoplasms 5 Glioblastoma 5 Lymphoma, Large B-Cell, Diffuse 4 Adenocarcinoma of Lung 4 Adenocarcinoma 4 Rectal Neoplasms 3 Melanoma 3 Leukoplakia, Oral 3 Insulin Resistance 3 Uterine Cervical Neoplasms 2 Urinary Bladder Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Neoplasm Metastasis 2 Liver Neoplasms 2 Leukemia, Myeloid, Acute 2 Hyperandrogenism 2 Esophageal Neoplasms 2 Erythroplasia 2 Diabetes Mellitus 2 Carcinoma, Ovarian Epithelial 2 Carcinoma, Hepatocellular 2 Brain Neoplasms 2

Interventions

Megestrol Acetate 4 Tirzepatide 2 Progestins 2 Atorvastatin 2 exemestane 1 estradiol, norethindrone drug combination 1 Rosuvastatin Calcium 1 Pterocarpus marsupium 1 Progesterone 1 Pharmacogenomic Variants 1 Metformin 1 Medroxyprogesterone Acetate 1 Levonorgestrel 1 Hysterectomy 1 Hydroxymethylglutaryl-CoA Reductase Inhibitors 1 Everolimus 1 Curettage 1 Biopsy 1 3,5-dimethoxy-4'-hydroxystilbene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01686126 2024-08-28

feMMe

Queensland Centre for Gynaecological Cancer

Phase 2 Active not recruiting

Endometrial Hyperplasia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡